HDL-Targeting Therapeutics: Past, Present and Future

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|8|1207-1215

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.8, 2017-04, pp. : 1207-1215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting HIV: Past, Present and Future

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 11, Iss. 2, 2011-04 ,pp. : 98-114

Bentham Science Publishers

Access to resources Recommend Favorite

Past, Present and Future Therapeutics for Cerebellar Ataxias

By  

Current Neuropharmacology, Vol. 8, Iss. 1, 2010-03 ,pp. : 41-61

Bentham Science Publishers

Access to resources Recommend Favorite

Past, Present, and Future of Targeting Ras for Cancer Therapies

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-03 ,pp. : 345-357

Bentham Science Publishers

Access to resources Recommend Favorite

Aurora kinase targeted therapeutics in oncology: past, present and future

By Mahadevan Daruka   Beeck Sunni  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 7, 2007-07 ,pp. : 1011-1026

Informa Healthcare

Access to resources Recommend Favorite

Tuberculosis Therapeutics: Past Achievements, Present Road-Blocks and Future Perspectives

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 4, 2004-10 ,pp. : 314-328

Bentham Science Publishers

Access to resources Recommend Favorite